ストックスクリーナーアプリを入手
54.94
1.84%
0.99
アフターアワーズ：
54.95
0.01
+0.02%
前日終値:
$53.95
開ける：
$53.76
24時間の取引高:
101.17K
Relative Volume:
0.32
時価総額：
$2.57B
収益：
-
当期純損益:
-
株価収益率:
-67.54
EPS:
-0.8135
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+10.63%
1か月 パフォーマンス:
+26.85%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$50.59
$55.42
1週間の範囲:
$48.76
$55.42
52週間の値動き範囲:
$23.00
$55.42
Hemab Therapeutics Holdings Inc Stock (COAG) Company Profile
名前
Hemab Therapeutics Holdings Inc
セクター
電話
45 2138 7627
住所
101 MAIN STREET, CAMBRIDGE
Compare COAG vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COAG
Hemab Therapeutics Holdings Inc
|
54.94 | 2.50B | 0 | 0 | 0 | -0.8135 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Hemab Therapeutics Holdings Inc (COAG) 最新ニュース
Novo Holdings A/S (COAG) discloses 9.0% beneficial stake in Hemab Therapeutics - Stock Titan
Avoro, Aghazadeh report 7.06% Hemab Therapeutics (COAG) ownership stake - Stock Titan
HC Wainwright Cuts Earnings Estimates for Hemab Therapeutics - MarketBeat
Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $64 - moomoo.com
Hemab Therapeutics (NASDAQ:COAG) Hits New 52-Week High After Analyst Upgrade - MarketBeat
Hemab Therapeutics (COAG): Capital International Investors discloses 7.7% ownership - Stock Titan
Hemab Therapeutics stock price target raised to $60 by H.C. Wainwright - Investing.com Canada
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
COAG SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
FMR LLC Acquires Stake in Hemab Therapeutics Holdings Inc (COAG) - GuruFocus
H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $60 - Moomoo
Hemab Therapeutics Reports Q2 2026 Financials and Pipeline Progress in Latest 10-Q Filing - Kalkine Media
Hemab Therapeutics (COAG) widens loss but builds $457.5M cash war chest - Stock Titan
Hemab Therapeutics (NASDAQ:COAG) Price Target Raised to $60.00 at HC Wainwright - MarketBeat
Hemab Therapeutics Gains FDA Backing to Advance Sutacimig Into Phase 3 Trial for Glanzmann Thrombasthenia - Minichart
Form 8K Hemab Therapeutics Holdings For: 11 August By Investing.com - Investing.com Nigeria
Earnings Flash (COAG) Hemab Therapeutics Posts Q2 Net Loss $0.80 a Share, vs. FactSet Est of $0.56 Loss - marketscreener.com
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Hemab Therapeutics reports Q2 2026 net loss of $24.2M, cash runway into 2029 after $317M IPO proceeds - TradingView
Hemab Unveils Peptide-Based Approach to Heavy Menstrual Bleeding - Stock Titan
COAG Stock Price and Chart — NASDAQ:COAG - TradingView
Hemab Therapeutics (NASDAQ: COAG) investors detail 5.1% passive ownership stake - Stock Titan
Hemab Therapeutics (NASDAQ:COAG) Hits New 1-Year HighTime to Buy? - MarketBeat
FMR LLC reports 7.9% Hemab Therapeutics (COAG) stake on Schedule 13G - Stock Titan
Sofinnova group (NASDAQ: COAG) discloses 5.4% Hemab Therapeutics ownership on Schedule 13G - Stock Titan
Hemab Therapeutics (NASDAQ:COAG) Trading Down 4.8%What's Next? - MarketBeat
Hemab Therapeutics Holdings Ord Shs (Proposed) - TradingKey
Hemab Therapeutics Holdings, Inc. Revenue Breakdown – NASDAQ:COAG - TradingView
Ra Capital Nexus Fund Iv, L.p. Net Worth (2026) - GuruFocus
Biotech stocks lead healthcare's overbought list as earnings picks up (XLV:NYSEARCA) - Seeking Alpha
Mads Nikolaj Behrndt Eriksen Net Worth (2026) - GuruFocus
Biotech IPO gains crush numerous AI listings - PressReader
Biotech IPO gains crush AI listings with standout 55% return - The Edge Singapore
Ananthram Sreenivasa Murthy Net Worth (2026) - GuruFocus
SpaceX Stock Closes At Fresh Low After Seven Straight Days Of Losses - Yahoo Finance
Ai Den Mab Llc Net Worth (2026) - GuruFocus
The Robot Maker's Paradox - Yahoo Finance
Hemab Therapeutics (NASDAQ:COAG) Hits New 12-Month HighWhat's Next? - MarketBeat
Culpeo Minerals expands Chile landholding by 45% with new licences - Yahoo Finance
After Plunging 32.2% in 4 Weeks, Here's Why the Trend Might Reverse for D-WAVE QUANTUM (QBTS) - Yahoo Finance
Insight Global Opens New Seattle Hub to Support Next Phase of Growth Across the Pacific Northwest - Yahoo Finance
DiamondRock Hospitality Company (DRH) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
IREN stock jumps as AI cloud contract wins lift annual revenue target - Yahoo Finance
Why this venture capitalist is bullish on Anthropic's IPO — not OpenAI's - Yahoo Finance
Plug Power vs. FuelCell: Both Are Hot in 2026, but Only One Is Worth Buying Now - Yahoo Finance
QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability - Yahoo Finance
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Why Is Lucid (LCID) Stock Rocketing Higher Today - Yahoo Finance
Sellas Life (SLS) Climbs 12% Ahead of ‘Potentially Company-Defining’ Clinical Trial Result - Yahoo Finance
Hemab Therapeutics (NASDAQ:COAG) Shares Up 5.5%Here's What Happened - MarketBeat
WESTSHORE TERMINALS ANNOUNCES AGREEMENT RENEWAL WITH EVR OPERATIONS LIMITED - Yahoo Finance
Hemab Therapeutics Holdings Inc (COAG) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):